CD274 and neoplasm: In preclinical studies with mice carrying tumor grafts, PF-06840003 reduced intratumoral kynurenic levels and inhibited tumor growth in both monotherapy and, with increased efficacy, in combination with antibodies blocking PDL-1 [143].